Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 7, 2020; 26(21): 2792-2809
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2792
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2792
Table 4 Percentage reduction of the mean relative tumor area
No. of case | k vs FOLFOXIRI (%) | k vs GEMOX (%) | k vs Gem/nab-P (%) | k vs Gemcitabine (%) |
1 | -74 | -59 | -67 | -60 |
2 | -62 | -40 | -73 | -15 |
3 | -69 | -6 | -27 | -58 |
4 | -41 | 24 | 10 | -37 |
5 | -4 | -28 | -34 | -46 |
6 | -66 | -32 | -46 | -20 |
7 | -23 | -20 | -44 | -56 |
8 | -60 | 47 | -3 | 0 |
9 | -56 | -74 | -62 | -41 |
10 | -45 | -1 | -55 | -51 |
11 | -55 | -55 | -46 | -49 |
12 | -38 | -49 | 1 | -21 |
13 | -49 | -51 | -29 | -23 |
14 | 34 | -30 | 69 | 32 |
15 | 54 | -8 | -38 | -14 |
- Citation: Di Franco G, Usai A, Funel N, Palmeri M, Montesanti IER, Bianchini M, Gianardi D, Furbetta N, Guadagni S, Vasile E, Falcone A, Pollina LE, Raffa V, Morelli L. Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine. World J Gastroenterol 2020; 26(21): 2792-2809
- URL: https://www.wjgnet.com/1007-9327/full/v26/i21/2792.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i21.2792